Results 31 to 40 of about 513,529 (353)

Prevalence of Cervical Cancer and Associated Factors Among Women Attended Cervical Cancer Screening Center at Gahandi Memorial Hospital, Ethiopia

Cancer Informatics, 2021
Background: Despite the fact that cervical cancer is preventable disease, it is the fourth most frequently diagnosed cancer and leading cause of cancer death in women.
Mulugeta Mekuria, Kebede Edosa, Mulualem Endeshaw, E. T. Bala, E. E. Chaka, Berhanu Senbeta Deriba, Bikila Tesfa   +6 more
semanticscholar   +1 more source

Knowledge on cervical cancer screening and vaccination among females at Oyibi Community

BMC Women's Health, 2021
Background Awareness about cervical cancer screening and vaccination in the developed countries are high as compared to the developing countries. Sixty to eighty percent (60–80%) of the women who develop cervical cancer in sub-Saharan Africa live in the ...
Evans Appiah Osei, Stella Appiah, Judith Elinam Gaogli, Ezekiel Oti-Boadi   +3 more
doaj   +1 more source

Cervical cancer screening

Current Oncology Reports, 2004
Although primary prevention of human papillomavirus (HPV) infections that are causally associated with invasive cervical cancer may be within our grasp, it is unlikely that these approaches will replace existing cervical cancer screening strategies for many years.
Dorothy J, Wiley, Bradley J, Monk, Emmanuel, Masongsong, Kristina, Morgan   +3 more
  +7 more sources

Visual techniques for cervical cancer screening in Colombia

Biomédica: revista del Instituto Nacional de Salud, 2019
Introduction: Direct visual inspection for cervical cancer screening remains controversial, whereas colposcopy-biopsy is considered the gold standard for diagnosis of preneoplastic cervical lesions.
Óscar Gamboa, Mauricio González, Jairo Bonilla, Joaquín Luna, Raul Murillo, Cervical Cancer Screening Study Group INC   +5 more
doaj   +1 more source

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses

British Journal of Cancer, 2021
The COVID-19 pandemic has disrupted cervical cancer screening services. Assuming increases to screening capacity are unrealistic, we propose two recovery strategies: one extends the screening interval by 6 months for all and the other extends the ...
A. Castañón, M. Rebolj, F. Pesola, P. Sasieni   +3 more
semanticscholar   +1 more source

Cervical cancer screening among HIV-positive women in urban Uganda: a cross sectional study

BMC Women's Health, 2022
Background Women living with Human Immunodeficiency Virus (HIV) are at a high risk for early development of cervical cancer. Adherence to cervical cancer prevention strategies in this population is vital for the early detection and treatment of cervical ...
Najjuka Sarah Maria, Connie Olwit, Mark Mohan Kaggwa, Rose Chalo Nabirye, Tom Denis Ngabirano   +4 more
doaj   +1 more source

Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries.

Journal of the American Medical Association (JAMA), 2020
Importance The World Health Organization is developing a global strategy to eliminate cervical cancer, with goals for screening prevalence among women aged 30 through 49 years.
J. Lemp, Jan‐Walter De Neve, H. Bussmann, Simiao Chen, J. Manne‐Goehler, M. Theilmann, M. Marcus, Cara Ebert, C. Probst, Lindiwe Tsabedze-Sibanyoni, L. Sturua, J. Kibachio, S. Moghaddam, J. Martins, D. Houinato, C. Houehanou, M. Gurung, G. Gathecha, F. Farzadfar, S. Dryden-Peterson, J. Davies, R. Atun, S. Vollmer, T. Bärnighausen, P. Geldsetzer   +24 more
semanticscholar   +1 more source

Knowledge about cervical cancer and barriers of screening program among women in Wufeng County, a high-incidence region of cervical cancer in China. [PDF]

PLoS ONE, 2013
Cervical cancer screening is an effective method for reducing the incidence and mortality of cervical cancer, but the screening attendance rate in developing countries is far from satisfactory, especially in rural areas.
Yao Jia, Shuang Li, Ru Yang, Hang Zhou, Qunying Xiang, Ting Hu, Qinghua Zhang, Zhilan Chen, Ding Ma, Ling Feng   +9 more
doaj   +1 more source

Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium

Radiology and Oncology, 2019
The Hybrid Capture 2 (HC2) High-Risk HPV DNA assay serves as a triage test in the Slovenian national cervical cancer screening programme ZORA. To improve the limited analytical accuracy of HC2 test results near the cut-off value (1.0 relative light units/
Varl Jerneja, Ivanus Urska, Marinsek Ziva Pohar, Jerman Tine, Valencak Anja Ostrbenk, Poljak Mario, Prevodnik Veronika Kloboves   +6 more
doaj   +1 more source

A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China

Infectious Agents and Cancer, 2022
Background Co-infection with HIV is a strong risk factor for cervical cancer development. It is unknown whether women with HIV in Guangxi, China are utilizing currently available cervical cancer screening services, what barriers they face, and if they ...
Ran Zhao, Shujia Liang, Deanna Teoh, Yunqing Fei, Xianwu Pang, Shalini Kulasingam   +5 more
doaj   +1 more source